Skip to main content
. 2018 May 10;2018(5):CD012069. doi: 10.1002/14651858.CD012069.pub2

Saieh 2004.

Methods A patient report of hospitalisation due to hypertension during methylphenidate treatment
Participants Diagnosis of ADHD: DSM‐IV (subtype: not stated)
Age: 8 years old
IQ: normal
Sex: male
Ethnicity: not stated
Country: Chile
Comorbidity: not stated
Comedication: not stated
Sociodemographics: maternal family history of hypertension
Interventions Methylphenidate type: Ritalin
Methylphenidate dosage: 0.32 mg/kg
Administration schedule: not stated
Duration of treatment: 6 months
Treatment compliance: not stated
Outcomes Serious adverse events:
72‐hour hospitalisation, emergency unit:
Abdominal pain for 4 days prior to hospitalisation, intermittent accentuation (hours), no other symptoms
Secondary hypertension: persistent hypertension (158/88 ‐ 170/105, pulse: 78‐98 bpm). Normal physical examination. Normal eye fundus and normal cardiological examination.
Discontinuation of methylphenidate: hypertensive treatment only necessary for 24 hours. Normal blood pressure after 1 week
Notes Key conclusions of the study authors: we want to draw attention to our experience of a patient who had hypertension, which was clearly related to the administration of MPH, and which disappeared when MPH was discontinued
Comments from the study authors: unfortunately, only a few relevant publications and no national studies on the subject exist, so we do not know exactly the extent of this problem, although from anecdotal experience of verbal communication the incidence of tachycardia and hypertension appear to be low. Prospective studies should be performed to find the true incidence of complications with the use of methylphenidate and thus further establish careful and appropriate control of MPH‐treated patients to avoid these complications
Funding/vested interest/authors affiliations: no affiliations to pharmaceutical companies stated
Supplemental information regarding ADHD diagnostic criteria, IQ, type and dose of MPH, and duration of hospitalisation received through personal email correspondence with the authors in October and December 2013 (Saieh 2013 [pers comm])